Back to Search
Start Over
In vivo Fate of Targeted Drug Delivery Carriers.
- Source :
-
International journal of nanomedicine [Int J Nanomedicine] 2024 Jul 09; Vol. 19, pp. 6895-6929. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- This review aimed to systematically investigate the intracellular and subcellular fate of various types of targeting carriers. Upon entering the body via intravenous injection or other routes, a targeting carrier that can deliver therapeutic agents initiates their journey. If administered intravenously, the carrier initially faces challenges presented by the blood circulation before reaching specific tissues and interacting with cells within the tissue. At the subcellular level, the car2rier undergoes processes, such as drug release, degradation, and metabolism, through specific pathways. While studies on the fate of 13 types of carriers have been relatively conclusive, these studies are incomplete and lack a comprehensive analysis. Furthermore, there are still carriers whose fate remains unclear, underscoring the need for continuous research. This study highlights the importance of comprehending the in vivo and intracellular fate of targeting carriers and provides valuable insights into the operational mechanisms of different carriers within the body. By doing so, researchers can effectively select appropriate carriers and enhance the successful clinical translation of new formulations.<br />Competing Interests: The authors declare that they have no competing interests in this work.<br /> (© 2024 Zhao et al.)
Details
- Language :
- English
- ISSN :
- 1178-2013
- Volume :
- 19
- Database :
- MEDLINE
- Journal :
- International journal of nanomedicine
- Publication Type :
- Academic Journal
- Accession number :
- 39005963
- Full Text :
- https://doi.org/10.2147/IJN.S465959